SuPAR
Showing 1 - 25 of 83
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Soluble Urokinase Plasminogen Activation Receptor to Rule Out
Not yet recruiting
- Soluble Urokinase Plasminogen Activation Receptor
- +3 more
- Soluble Urokinase Plasminogen Activation Receptor measurement
-
Poitiers, FranceCHU of Poitiers
Jan 5, 2023
Contribution of SuPAR forSituation of Uncertainty Downstream of
Completed
- Emergencies
- +2 more
- blood supar measurement
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Apr 25, 2022
Critical Illness Trial in Helsinki (suPAR algoritm)
Completed
- Critical Illness
- suPAR algoritm
-
Helsinki, Helsinki Usimaa, FinlandDepartment of Emergency Medicine and Services, Helsinki Universi
Jan 28, 2022
SuPAR in Adult Patients With Covid-19
Completed
- Covid19
- Soluble Urokinase Plasminogen Activator Receptor
-
Larissa, Thessaly, GreeceUniversity Hospital of Larisa, Department of Anesthesiology
Oct 16, 2021
Initial Investigation of Patients With Suspected Pneumonia
Active, not recruiting
- Pneumonia, Bacterial
- PCT
- +2 more
-
Aabenraa, DenmarkHospital of Southern Jutland
Apr 19, 2022
International Study of Inflammation in COVID-19
Recruiting
- Covid19
- +4 more
- SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
-
Ann Arbor, MichiganUniversity of Michigan
Aug 17, 2022
Blood Samples of Breast Cancer Patients During and Post
Completed
- Doxorubicin Adverse Reaction
- +2 more
-
Chicago, Illinois
- +1 more
Apr 23, 2021
Patients Hospitalized for Acute Heart Failure According to
Completed
- Heart Failure
- Evaluation of the evolution of biological markers from the biobank.
-
Nîmes, Gard, France
- +1 more
Jul 26, 2022
Triage, Risk Stratification With Biomarker Trial in Herlev (suPAR measurement)
Completed
- Triage
- Risk Stratification With Biomarker
- suPAR measurement
-
Herlev, DenmarkHerlev Hospital, Department of Cardiology
Feb 16, 2021
MDD, Bipolar Disorder, Bipolar Depression Trial in Porto Alegre (Ketamine)
Recruiting
- Major Depressive Disorder
- +5 more
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clinicas de Porto Alegre
Feb 18, 2022
Diagnostic and Prognostic Biomarkers of Sepsis
Completed
- Sepsis
-
Sohag, EgyptFaculty of medicine - sohag university
Feb 21, 2021
Septic Shock, Sepsis, Severe Trial in Izmir (suPAR)
Completed
- Septic Shock
- Sepsis, Severe
- suPAR
-
İzmir, TurkeyEge University School of Medicine
Jul 6, 2020
Role of suPAR in Periodontitis and CVD
Completed
- Metabolic Disturbance
- Periodontal Diseases
- Observation of suPAR plasma and salivary levels
-
Messina, ItalyUniversity of Messina
Apr 3, 2020
suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery
Completed
- Thoracic Surgery
- +2 more
- Blood sampling
-
Copenhagen, DenmarkDepartment of Cardiothoracic Anaesthesiology, Rigshospitalet
Feb 27, 2020
Predict Sepsis; Predictive Value of Bedside Measures in
Completed
- Sepsis
- +2 more
- Blood test: Glukos, SuPAR, Laktat and HBP
-
Stockholm, SwedenSamariten Ambulans AB
Oct 25, 2020
Cytokine Profiles and suPAR in Spondylodiscitis
Completed
- Spondylodiscitis
- Cytokine Profile and suPAR
-
Cologne, NRW, GermanyStudienzentrum Orthopädie & Unfallchirurgie
Aug 9, 2019
DVT of Legs Trial in Hvidovre (Blood sample and Ultrasound examination)
Recruiting
- DVT of Legs
- Blood sample and Ultrasound examination
-
Hvidovre, Copenhagen, DenmarkCopenhagen University Hospital Hvidovre
Mar 15, 2023
The Role of Ischemia Modified Albumin in Patients With COVID-19
Recruiting
- COVID-19
- Ischemia Modified Albumin
-
Larissa, Thessalia, GreeceLarissa University Hospital
May 4, 2022
End-stage Heart Failure Trial in Bron (Dapagliflozin 10mg, Placebo)
Not yet recruiting
- End-stage Heart Failure
- Dapagliflozin 10mg
- Placebo
-
Bron, FranceHôpital Pneumologique et Cardiovasculaire Louis Pradel
Jul 5, 2022
Coronary Artery Disease Trial in Atlanta (Medical/Behavioral therapy, Standard of Care, Registry)
Recruiting
- Coronary Artery Disease
- Medical/Behavioral therapy
- +2 more
-
Atlanta, Georgia
- +4 more
Oct 21, 2022
Plasma Soluble Urokinase Plasminogen Activator Receptor and
Not yet recruiting
- Behçet Disease
- (no location specified)
Jan 11, 2021
Primary Focal Segmental Glomerulosclerosis Trial in Chicago, Rochester, Toronto (Rituximab)
Completed
- Primary Focal Segmental Glomerulosclerosis
- Rituximab
-
Chicago, Illinois
- +3 more
Jan 29, 2020